Skip to main content
Caplight Logo









Fosanis GmbH

Fosanis GmbH

Private
BerlinHealthcare & Life Scienceshttps://mitmika.de/

Last Round

Series A

May 9, 2022

Total Funding Raised

$10.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fosanis GmbH is a digital health company that develops Mika, an AI-powered digital therapeutic platform designed to support cancer patients with personalized monitoring, coaching, and evidence-based therapy management.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics, Telemedicine, Medical AI

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

digital therapeuticDTxoncology supportdigital healthDiGAhealthtechsymptom monitoringpsycho-oncologyePROpatient engagementmedical apppersonalized coachingcancer careprescription apptelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fosanis GmbH Comparables

Compare Fosanis GmbH with similar companies based on industry and business-model similarity.

Fosanis GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CANKADO GmbH
85%
mobile Health AG
83%
Prosoma
82%

Fosanis GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 9, 2022
SeedAug 6, 2019

Fosanis GmbH Investors

Notable investors and investment history

Fosanis GmbH investors
InvestorRounds
EquityPitcher VenturesSeries A
IBB BeteiligungsgesellschaftSeed
Ship2B VenturesSeries A
Ananda VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 210% MoM, reaching 5.7K.

  • Mar 3, 2026

    Monthly visitors increased 59% MoM.

Fosanis GmbH Filings

Explore SEC and related filing metadata, where available.

Fosanis GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fosanis GmbH's valuation, stock price, and market status.

Is Fosanis GmbH a public or private company?

Fosanis GmbH is a private company.

What is the current stock price of Fosanis GmbH?

Fosanis GmbH is a private company, so its shares have no public market price. Caplight tracks Fosanis GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Fosanis GmbH worth (valuation)?

Valuation information for Fosanis GmbH is not publicly available.

Can I buy Fosanis GmbH stock?

Fosanis GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Fosanis GmbH's last funding round?

Fosanis GmbH's most recent funding round was Series A on May 9, 2022.

Who are the main investors in Fosanis GmbH?

Key investors in Fosanis GmbH include EquityPitcher Ventures, IBB Beteiligungsgesellschaft, Ship2B Ventures, Ananda Ventures.

Will Fosanis GmbH IPO soon?

No public IPO plans have been announced for Fosanis GmbH.

How can I track Fosanis GmbH secondary market activity?

Caplight tracks bids, offers, and trades in Fosanis GmbH's shares on secondary markets.

Firmographic Details

HeadquartersBerlin
Employee Range59
Year Founded2017
Last FundingMay 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?